Six AIS-A quadriplegic volunteers received 10 million AST-OPC1 cells in Asterias Biotherapeutics SCIstar trial. For the five patients who have completed at least 6 months of follow-up all have seen improvements in their motor function, Read more…
Month: January 2017
Queensland researchers are launching a world-first clinical trial aimed at improving recovery from spinal cord injuries.
In the study, led by The University of Queensland and The Princess Alexandra (PA) Hospital, a new anti-inflammatory drug will be given to participants within hours of spinal trauma in an effort to minimise tissue damage. The results of this…
Reprogramming embryonic stem cells to expand their potential cell fates
Researchers from the University of California, Berkeley, have found a way to reprogram mouse embryonic stem cells so that they exhibit developmental characteristics resembling those of fertilized eggs, or zygotes. For now, the new stem cell lines UC Berkeley researchers have…